试用视觉搜索
使用图片进行搜索,而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索,请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
2804×1577
www.fiercebiotech.com
The 10 highest value R&D projects in biopharma
2121×1414
www.fiercebiotech.com
Novo Nordisk hails ‘remarkable’ weight loss result for dual-actin…
5000×2813
www.fiercebiotech.com
Applied Therapeutics fails heart disease phase 3, seeks partner to ...
5904×3321
www.fiercebiotech.com
Allogene makes ‘bold’ pivot, stopping pivotal trials in pursuit of ...
2121×1193
www.fiercebiotech.com
Novartis closes San Diego R&D site as part of restructure plan
6541×3680
www.fiercebiotech.com
Cancer-focused Actuate makes 2nd tweak to IPO plans in a week
2000×1125
www.fiercebiotech.com
MeiraGTx gifts last of gene therapy rights to J&J for $415M
3000×1688
www.fiercebiotech.com
Study shows gains with ablation before meds in treating v-tach after ...
1732×1732
www.fiercebiotech.com
Jay Bradner tapped to lead R&D at Amgen …
4442×2500
www.fiercebiotech.com
J&J opens the valve on $50M MS partnership with Pipeline
1999×1123
www.fiercebiotech.com
Incyte's $750M buyout rocked by pause on key trial, asset cull
1999×1123
www.fiercebiotech.com
Sebastian Guth takes reins of Bayer’s US operations—Chutes & Ladders
8659×4870
www.fiercebiotech.com
67% of new drugs came from emerging biopharmas in '22: IQVIA
2121×1414
www.fiercebiotech.com
Agenus lays off 25%, sidelines programs to focus on cancer co…
4820×2711
www.fiercebiotech.com
CRISPR pioneer looks to tech's past, future in new review
2120×1192
www.fiercebiotech.com
Sarepta axes late-phase DMD drug over safety signal, FDA talks
3181×2122
www.fiercebiotech.com
Edwards excites with Evoque FDA approval in transcatheter tricusp…
5000×2812
www.fiercebiotech.com
Lundbeck taps Charles River for AI-enabled neuro drug discovery
3000×1688
www.fiercebiotech.com
FDA approves Medtronic’s rechargeable deep brain stimulator for ...
2309×1298
www.fiercebiotech.com
Genmab axes 3 programs to focus on plumped-up pivotal pipeline
2500×1407
www.fiercebiotech.com
Zenas, Bicara set out to raise $180M-plus in separate IPOs
7424×4176
www.fiercebiotech.com
Dyne shakes up C-suite after hazy DMD data drop
2059×1456
www.fiercebiotech.com
CRISPR Therapeutics laid off staff a week after positive adc…
5000×2812
www.fiercebiotech.com
Gilead pays $4.3B for CymaBay's late-stage liver disease med
2088×1170
www.fiercebiotech.com
100 days with John Crowley: Behind BIO’s new structure & vision
5000×2693
www.fiercebiotech.com
New AI drug discovery powerhouse Xaira rises with $1B in funding
2000×1125
www.fiercebiotech.com
After hunt for buyer fails, Aurinia lays off 25%, drops R&D
1904×1075
www.fiercebiotech.com
Ocuphire to transform into gene therapy biotech via Opus buyout
2138×1401
www.fiercebiotech.com
New gene therapy for epilepsy hits seizures where they start
2508×1672
www.fiercebiotech.com
GE HealthCare plots 2023 growth in first solo earnings report
2000×1129
www.fiercebiotech.com
Radiopharma Alpha-9 raises $175M series C to fund clinical push
1920×1080
www.fiercebiotech.com
Phase 2 data will drive biopharma VC investment in 2025: PitchBook
2309×1299
www.fiercebiotech.com
Lundbeck signs $2.5B check for Longboard and its epilepsy med
3000×1688
www.fiercebiotech.com
Sanofi to surf Belharra in $700M biobucks immunology deal
2163×1210
www.fiercebiotech.com
Ensho emerges with phase 2-ready asset from Eisai unit
某些结果已被隐藏,因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈